Lv2
116 积分 2021-04-10 加入
Identification of a tumour immune barrier in the HCC microenvironment that determines the efficacy of immunotherapy
13天前
已完结
A conserved re-epithelialization program underlies malignancy in pancreatic ductal adenocarcinoma
28天前
已完结
CellChat for systematic analysis of cell–cell communication from single-cell transcriptomics
1个月前
已完结
A scalable SCENIC workflow for single-cell gene regulatory network analysis
1个月前
已完结
Daraxonrasib in Previously Treated Advanced RAS -Mutated Pancreatic Cancer
2个月前
已完结
Final Overall Survival Efficacy Results of Ivosidenib for Patients With Advanced Cholangiocarcinoma With IDH1 Mutation
3个月前
已完结
Adjuvant Chemoradiation and Immunotherapy for Extrahepatic Cholangiocarcinoma and Gallbladder Cancer
3个月前
已完结
A Phase 2 Multi-institutional Study of Nivolumab for Patients With Advanced Refractory Biliary Tract Cancer
3个月前
已完结
Nivolumab alone or in combination with cisplatin plus gemcitabine in Japanese patients with unresectable or recurrent biliary tract cancer: a non-randomised, multicentre, open-label, phase 1 study
3个月前
已完结
Real-world efficacy of zanidatamab in patients with HER2 positive advanced biliary tract cancers
3个月前
已完结
皖公网安备34019202002308
